Trinity Biotech (TRIB) Shares Outstanding (Weighted Average) (2009 - 2025)

Trinity Biotech has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $40000.0 for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $40000.0, down 99.05% year-over-year; the trailing twelve-month figure through Dec 2025 was $40000.0 (down 99.05% YoY), and the FY2025 annual result was $40000.0, down 99.05% from the prior year.
• Shares Outstanding (Weighted Average) came in at $40000.0 for Q4 2025 at Trinity Biotech, down from $63.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.2 billion in Q1 2021 to a low of $40000.0 in Q4 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $51.6 million (2022), against an average of $249.9 million.
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 112.73% in 2023 and plunged 99.05% in 2025, its largest moves.
• Trinity Biotech's Shares Outstanding (Weighted Average) stood at $83.6 million in 2021, then surged by 61.4% to $134.9 million in 2022, then climbed by 13.46% to $153.1 million in 2023, then plunged by 97.26% to $4.2 million in 2024, then slumped by 99.05% to $40000.0 in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $40000.0 (Q4 2025), $63.8 million (Q2 2025), and $4.2 million (Q4 2024), per Business Quant data.